A Phase 4 interventional study of Norco 5Mg-325Mg Tablet and Ibuprofen 600 mg in Knee Injuries, Pain, Postoperative and Opioid Use, sponsored by Sanford Health. Recruiting at 1 site in United States. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-02-10.
Sponsored by Sanford Health · Phase 4, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 94 studies in Knee Injuries with a site in United States — 16 open to participants now, 24 under way, 1 of them phase 3. Knee Injuries · United States.
Among the 94 studies in Knee Injuries with a site in United States, this one is the 8th largest by planned enrollment of the 75 interventional ones that give a count, is one of 8 that started in 2018, is one of 2 in phase 4, reaches primary completion later than 17 of the 23 other live ones, and was the 45th registered.
267 studies on the registry are indexed under Knee Injuries; 59 are open to participants now.
Browse Knee Injuries studies →16 of the 94 studies in Knee Injuries with a site in United States are open now. Recruiting first, the newest first:
Smith & Nephew, Inc. · Sites in United States
Ages 18+
University of Central Florida · Sites in United States
Ages 18–30 · Healthy volunteers
Stryker Endoscopy · Sites in United States
Ages 18+
University of North Carolina, Chapel Hill · Sites in United States
Ages 16–35
Connecticut Children's Medical Center · Sites in United States
Ages 12–18
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 42 Knee Injuries studies recruiting now, 12 (29%) set no upper age limit and 27 (64%) stop at 75 or younger; 12 take children under 18; 9 take healthy volunteers.
This study: 18 Years to 80 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
94 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 4 · Phase 2 5 · Phase 3 10 · Phase 4 2
First in 2002; this study’s year is marked. 8 started in 2018.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 148 is above the median of 49 across 178 interventional studies indexed under Knee Injuries.
Median enrollment 40 across the 75 interventional studies, 170 across the 19 observational. Of the 59 that completed or were terminated, 26 (44%) have results posted.
This tab as a report to print or save as PDF → With an account.
18 of 94 have an industry lead sponsor. The 10 most frequent:
Sanford Health is the lead sponsor of 40 studies on the registry; 9 are open to participants now.
Sanford Health has 1 study filed under Knee Injuries — fewer than ten, so there is no comparison to draw.
12 of the studies in Knee Injuries with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05652270Dartmouth-Hitchcock Medical CenterMaximizing Patient Goal Attainment | 2026-11-30 |
| NCT05824676Hartford HospitalDePuy Synthes Variable Angle LCP Patella Plating System Study | 2026-12 |
| NCT04109638Stanford UniversityPulsed Electromagnetic Field (PEMF) Therapy for Post-operative Pain Following Orthopedic Surgery | 2027-02 |
| NCT06916728Smith & Nephew, Inc.A Post Approval Multicenter 10 Year Follow-up Observational Trial of Marketed Product - MP01 vs. Surgical Standard of Care (SSOC) Used for the Treatment of Joint Surface Lesions of the Knee | 2027-02-05 |
| NCT03543098University of PittsburghSTaR Trial: Multiple Ligament Knee Injuries | 2027-06 |
Add all 12 to your calendar (.ics) → With an account.
Among the 94 studies in Knee Injuries with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of this study is to look at pain management with opioids versus non-opioids after knee arthroscopy. This study will determine 1) whether the most commonly used non-narcotic medications provide pain relief comparable with the most commonly prescribed narcotic medications in patients undergoing arthroscopic knee surgery, and 2) whether patients' characteristics (gender, pre-operative knee symptoms, workers compensation status and employment status) affect pain level following surgery or medication usage.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Drug: Norco 5Mg-325Mg Tablet
Drug: Ibuprofen 600 mg · Drug: Acetaminophen 325Mg Tab
Drug pages: HydrocodoneStudies of HydrocodoneHydrocodone pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record. · AcetaminophenStudies of AcetaminophenAcetaminophen pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.
1 tablet up to 4 times per day for 7 days
1 tablet up to 4 times per day for 7 days
1 tablet up to 4 times per day for 7 days
Change from Baseline Pain Assessment at 2 weeks
Visual Analog Scale from 0 to 10 with 0 being no pain and 10 being worst possible, unbearable, excruciating pain
Time frame: Daily for 2 weeks post-operatively
Change from Baseline Medication Use at 2 weeks
Patients will be asked how many study medication capsules have they taken.
Time frame: Daily for 14 days post-operatively
Change from Baseline Knee Injury and Osteoarthritis Outcome Score (KOOS) at 6 weeks
Sub-scales are listed as follows: 5 qualitative questions related to knee symptoms ranging from "never" to "always", 2 qualitative questions related to knee stiffness ranging from "none" to "extreme", 9 qualitative questions related to pain ranging from "none" to "extreme", 17 qualitative questions related to function and daily living ranging from "none" to "extreme", 5 qualitative questions related to function and sports and recreational activities ranging from "none" to "extreme", and 4 qualitative questions related to quality of life ranging from "never or not at all" to "constantly, totally, or extreme".
Time frame: baseline, 2 weeks, and 6 weeks post-operatively
Change from Baseline Patient Reported Outcome Measurement Information System (PROMIS) at 6 weeks
7 qualitative questions related to pain interference with responses ranging from "not at all" to "very much"
Time frame: baseline, 2 weeks, and 6 weeks post-operatively
Started Oct 2018 (actual). Primary completion is estimated for Dec 2027, 110 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drugs tested here: Hydrocodone · Acetaminophen · Ibuprofen
Sanford Health